About US
Contact us
-
States follow feds with accusations of generic price fixing against Mylan, Heritage, othersGeneric drugmakers have received yet another holiday surprise. Just a day after federal authorities released the initial salvo into an alleged price-fixing scheme by charging two former Heritage Pharm2017/1/18
-
Pfizer wins quick reward from buyout of Anacor with approval of eczema drug expected to be blockbusterScore a big win for Pfizer and its $4.5 billion buyout of Anacor Pharmaceuticals. The FDA Wednesday approved Anacor'seczema treatmentthat is projected to be a $2 billion blockbuster. The FDAapprovedE2017/1/17
-
Ex-Heritage Pharma execs first up for federal charges in generics price-fixing probeJust a month after details of a wide-ranging generics price fixing probe made their way to the public, the Justice Department has stepped forward with its first charges. Prosecutors are determined the2017/1/17
-
Bristol-Myers to pay $19.5 million in Abilify off-label marketing settlementAlmost a decade after settling up Abilify marketing allegations with the U.S. Justice Department, Bristol-Myers Squibb agreed to pay $19.5 million to settle similar claims at the state level. Announc2017/1/16
-
States follow feds with accusations of generic price fixing against Mylan, Heritage, othersGeneric drugmakers have received yet another holiday surprise. Just a day after federal authorities released the initial salvo into an alleged price-fixing scheme by charging two former Heritage Pharm2017/1/16
-
Pfizer wins quick reward from buyout of Anacor with approval of eczema drug expected to be blockbusterScore a big win for Pfizer and its $4.5 billion buyout of Anacor Pharmaceuticals. The FDA Wednesday approved Anacor'seczema treatmentthat is projected to be a $2 billion blockbuster. The FDAapprovedE2017/1/13
-
Ex-Heritage Pharma execs first up for federal charges in generics price-fixing probeJust a month after details of a wide-ranging generics price fixing probe made their way to the public, the Justice Department has stepped forward with its first charges. Prosecutors are determined the2017/1/13
-
Bristol-Myers to pay $19.5 million in Abilify off-label marketing settlementAlmost a decade after settling up Abilify marketing allegations with the U.S. Justice Department, Bristol-Myers Squibb agreed to pay $19.5 million to settle similar claims at the state level. Announc2017/1/12
-
Trump wants to battle high drug prices? Let's work together, hike-fighting senator saysSen. Amy Klobuchar, who early on called for an investigation into Mylan’s EpiPen prices, has a message for President-elect Donald Trump: Let’s bring drug prices down together. In a newop-edfor USA2017/1/12
-
Zetia generics launch sets Merck up for $1.4B hit to 2017 cholesterol salesMerck & Co.'s big-selling cholesterol-fighter Zetia is at the end of its exclusive road. The $2.5 billion sellernow faces its first generic competitor, which threatens not only its own revenue, bu2017/1/11